VERONA PHARMA PLC. — Revenue by Fiscal Year
5 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/604aa6d5-46c6-4e3b-a610-f02512986fe7/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2024 | $42.3M | 2024-01-01 – 2024-12-31 | evidence 0001657312-25-000010 |
| FY 2023 | $0 | 2023-01-01 – 2023-12-31 | evidence 0001657312-24-000007 |
| FY 2022 | $458.0k | 2022-01-01 – 2022-12-31 | evidence 0001657312-23-000006 |
| FY 2021 | $40.0M | 2021-01-01 – 2021-12-31 | evidence 0001657312-22-000010 |
| FY 2020 | $0 | 2020-01-01 – 2020-12-31 | evidence 0001657312-22-000010 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
VERONA PHARMA PLC. — all facts · Net Income · Operating Income